Top Upgrades
- Deutsche Bank upgraded Saia Inc SAIA from Hold to Buy. Saia shares fell 3.47 percent to close at $64.84 on Wednesday.
- Baird upgraded Cummins Inc. CMI from Neutral to Outperform. Cummins shares fell 0.6 percent to $148.40 in pre-market trading.
- Goldman Sachs upgraded Spirit Airlines Incorporated SAVE from Neutral to Buy. Spirit Airlines shares fell 3.26 percent to close at $60.90 on Wednesday.
- Credit Suisse upgraded Bloom Energy Corp BE from Neutral to Outperform. Bloom Energy shares fell 1 percent to $10.06 in pre-market trading.
- Raymond James upgraded MacroGenics Inc MGNX from Underperform to Market Perform. Macrogenics shares rose 4.7 percent to $26.80 in pre-market trading.
- Macquarie upgraded Suncor Energy Inc. SU from Neutral to Outperform. Suncor Energy shares rose 0.3 percent to $33.30 in pre-market trading.
- SunTrust Robinson Humphrey upgraded Healthequity Inc HQY from Hold to Buy. HealthEquity rose 4 percent to $69.09 in pre-market trading.
- Leerink Swann upgraded Zafgen Inc ZFGN from Market Perform to Outperform. Zafgen shares fell 0.88 percent to close at $4.52 on Wednesday.
- Jefferies upgraded Guess?, Inc. GES from Hold to Buy. Guess? shares rose 1.6 percent to $20.55 in pre-market trading.
- Analysts at Baird upgraded PACCAR Inc PCAR from Neutral to Outperform. PACCAR shares rose 1.2 percent to $66.32 in pre-market trading.
Top Downgrades
- BTIG Research downgraded FireEye Inc FEYE from Buy to Neutral. FireEye shares fell 11.5 percent to $16.30 in pre-market trading.
- Oppenheimer downgraded Cummins Inc. CMI from Outperform to Perform. Cummins shares fell 0.6 percent to $148.40 in pre-market trading.
- Bank of America downgraded Owens-Illinois Inc OI from Buy to Neutral. Owens-Illinois shares rose 0.03 percent to $19.72 in pre-market trading.
- Morgan Stanley downgraded Vale SA VALE from Overweight to Equal-Weight. Vale shares rose 0.4 percent to $11.40 in pre-market trading.
- Goldman Sachs downgraded Elastic NV ESTC from Buy to Neutral. Elastic shares fell 7.2 percent to $82.00 in pre-market trading.
- Stifel Nicolaus downgraded Omega Healthcare Investors Inc OHI from Buy to Hold. Omega Healthcare shares fell 0.3 percent to $39.25 in pre-market trading.
- Susquehanna downgraded First Data Corp FDC from Positive to Neutral. First Data shares fell 0.01 percent to $25.15 in pre-market trading.
- Craig-Hallum downgraded FormFactor, Inc. FORM from Buy to Hold. FormFactor shares rose 2.1 percent to $15.60 in pre-market trading.
- Jefferies downgraded Essex Property Trust Inc ESS from Buy to Hold. Essex Property Trust shares fell 0.51 percent to close at $275.51 on Wednesday.
- JP Morgan downgraded Banco Santander Mexico Sa Instcn De BSMX from Overweight to Neutral. Banco Santander Mexico shares rose 0.8 percent to $7.36 in pre-market trading.
Top Initiations
- Cantor Fitzgerald initiated coverage on Spectrum Pharmaceuticals, Inc. SPPI with an Overweight rating. The price target for Spectrum Pharmaceuticals is set to $19. Spectrum Pharmaceuticals shares closed at $11.23 on Wednesday.
- Loop Capital initiated coverage on XPO Logistics Inc XPO with a Buy rating. The price target for XPO Logistics is set to $75. XPO Logistics shares closed at $59.31 on Wednesday.
- Raymond James initiated coverage on Cactus Inc WHD with a Strong Buy rating. The price target for Cactus is set to $39. Cactus shares closed at $33.38 on Wednesday.
- Analysts at BTIG Research initiated coverage on 3Pea International Inc TPNL with a Buy rating. The price target for 3Pea International is set to $6. 3Pea International shares closed at $4.92 on Wednesday.
- Baird initiated coverage on Iovance Biotherapeutics Inc IOVA with an Outperform rating. The price target for Iovance Biotherapeutics is set to $29. Iovance Biotherapeutics shares closed at $9.83 on Wednesday.
- Buckingham initiated coverage on Fiserv Inc FISV with a Buy rating. Fiserv shares closed at $84.61 on Wednesday.
- Analysts at Scotiabank initiated coverage on Omega Healthcare Investors Inc OHI with a Sector Perform rating. Omega Healthcare shares closed at $39.37 on Wednesday.
- Analysts at B. Riley FBR initiated coverage on G1 Therapeutics Inc GTHX with a Buy rating. The price target for G1 Therapeutics is set to $55. G1 Therapeutics closed at $20.70 on Wednesday.
- Baird initiated coverage on Cellular Biomedicine Group Inc CBMG with an Outperform rating. The price target for Cellular Biomedicine is set to $26. Cellular Biomedicine shares closed at $17.62 on Wednesday.
Loading...
Loading...
BEBloom Energy Corp
$19.981.11%
Edge Rankings
Momentum
47.49
Growth
99.11
Quality
Not Available
Value
14.81
Price Trend
Short
Medium
Long
CMICummins Inc
$323.04-0.99%
ESSEssex Property Trust Inc
$278.171.30%
ESTCElastic NV
$93.010.17%
FORMFormFactor Inc
$31.88-0.22%
GESGuess? Inc
$11.170.45%
HQYHealthEquity Inc
$101.460.32%
IOVAIovance Biotherapeutics Inc
$1.761.73%
MGNXMacrogenics Inc
$1.44-3.03%
OHIOmega Healthcare Investors Inc
$36.54-0.87%
OIO-I Glass Inc
$13.06-2.61%
PCARPACCAR Inc
$94.90-0.07%
SAIASaia Inc
$268.10-2.51%
SUSuncor Energy Inc
$35.33-1.09%
VALEVale SA
$9.46-0.85%
WHDCactus Inc
$41.51-1.61%
XPOXPO Inc
$122.272.91%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in